Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/07/044150
CTRI/2022/07/044150
Not yet recruiting
未知

Clinical Efficacy Of Herbal Compound In Irritable Bowel Syndrome

Himalayiya Ayurvedic Medical College and Hospital Dehradun0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: K928- Other specified diseases of the digestive system

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K928- Other specified diseases of the digestive system
Sponsor
Himalayiya Ayurvedic Medical College and Hospital Dehradun
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Himalayiya Ayurvedic Medical College and Hospital Dehradun

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients willing to participate in the study.
  • •2\.Patients irrespective of sex, religion, occupation will be selected for study with age between 18\-70 years.
  • •3\.Patients having sign and symptoms of Grahani Dosha and who are diagnosed with IBS according to standard ROME IIIrd criteria.
  • •4\.Previously diagnosed case of IBS

Exclusion Criteria

  • •1\.Patients not willing to participate in the study.
  • •2\.Patients of either sex below 18 years \& above 70 years will be excluded from the study.
  • •3\.Ulcerative colitis, Crohnâ??s disease, gastric ulcerations and other inflammatory bowel
  • •conditions, Parasitic infestation
  • •4\.Amoebic dysentery, acute diarrhoea, bleeding per rectum
  • •5\.Patients on prolonged medication with NSAIDs, analgesics or any other drugs that may have an influence on the outcome of the study
  • •6\.Alcoholic and/or drug abusers.
  • •7\.History of hypersensitivity to the trail drugs or any of its ingredients.
  • •8\.Pregnant /lactating woman.
  • •9\.Patients who have completed participation in any other clinical trial during the past 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Clinical effects of a herbal formulation in relieving inflammation and joint painsosteoarthritis.Arthrosis, unspecified
IRCT20131219015870N2Vice chancellor for research of Kermanshah University of Medical Sciences60
Not yet recruiting
Phase 2
Clinical evaluation of herbal formulations in adults with acute/chronic pain and inflammatioHealth Condition 1: M179- Osteoarthritis of knee, unspecified
CTRI/2023/07/055425Plant Ayu Life Sciences LLP Pune
Completed
Phase 3
Efficacy and Safety of an Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence: A Prospective, Placebo Controlled, Randomized, double-blinded Parallel-Group Comparison for SuperiorityAcute Otitis Media (AOM)H65.0 und H66.0Upper respiratory tract infectionH65.0H66.0Acute serous otitis mediaAcute suppurative otitis media
DRKS00004569Weber & Weber GmbH & Co. KGBiologische Arzneimittel311
Active, not recruiting
Not Applicable
Does a herbal-based medicine compared with a placebo (dummy drug) reduce the number of episodes with middle ear infection?recurrent acute otitis mediaMedDRA version: 16.1Level: PTClassification code 10033078Term: Otitis mediaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: PTClassification code 10033079Term: Otitis media acuteSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]
EUCTR2012-000341-13-DEWeber & Weber GmbH & Co. KG
Completed
Phase 2
Role of Herbal Immunomodulators in mild COVID-19 confirmed cases
CTRI/2020/06/025801The Himalaya Drug Company40